The Protective A673T Mutation of Amyloid Precursor Protein (APP) in Alzheimer's Disease

被引:22
作者
Xia, Qing [1 ]
Yang, XinYu [1 ]
Shi, JiaBin [1 ]
Liu, ZiJie [1 ]
Peng, YaHui [1 ,2 ,3 ,4 ]
Wang, WenJing [1 ]
Li, BoWen [1 ]
Zhao, Yu [1 ]
Xiao, JiaYing [1 ]
Huang, Lei [1 ]
Wang, DaYong [1 ,2 ,3 ,4 ]
Gao, Xu [1 ,2 ,3 ,4 ]
机构
[1] Harbin Med Univ, Dept Biochem & Mol Biol, Harbin, Peoples R China
[2] Heilongjiang Med Sci Acad, Basic Med Inst, Harbin, Peoples R China
[3] Translat Med Ctr Northern China, Harbin, Peoples R China
[4] Harbin Med Univ, Key Lab Heilongjiang Prov Genetically Modified An, Harbin, Peoples R China
基金
黑龙江省自然科学基金; 中国国家自然科学基金; 中国博士后科学基金;
关键词
Alzheimer’ s disease; Amyloid precursor protein; Amyloid beta; A673T mutation; Aggregation; Treatment; STEM-CELL LINE; GENE-THERAPY; GAMMA-SECRETASE; BETA; VARIANT; CLEAVAGE; DRUG; RISK; TAU; PHOSPHORYLATION;
D O I
10.1007/s12035-021-02385-y
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease is a progressive neurodegenerative disorder characterized by extracellular amyloid beta peptides and neurofibrillary tangles consisted of intracellular hyperphosphorylated Tau in the hippocampus and cerebral cortex. Most of the mutations in key genes that code for amyloid precursor protein can lead to significant accumulation of these peptides in the brain and cause Alzheimer's disease. Moreover, some point mutations in amyloid precursor protein can cause familial Alzheimer's disease, such as Swedish mutation (KM670/671NL) and A673V mutation. However, recent studies have found that the A673T mutation in amyloid precursor protein gene can protect against Alzheimer's disease, even if it is located next to the Swedish mutation (KM670/671NL) and at the same site as A673V mutation, which are pathogenic. It makes us curious about the protective A673T mutation. Here, we summarize the most recent insights of A673T mutation, focus on their roles in protective mechanisms against Alzheimer's disease, and discuss their involvement in future treatment.
引用
收藏
页码:4038 / 4050
页数:13
相关论文
共 101 条
  • [1] Bapineuzumab for mild to moderate Alzheimer's disease: a meta-analysis of randomized controlled trials
    Abushouk, Abdelrahman Ibrahim
    Elmaraezy, Ahmed
    Aglan, Amro
    Salama, Reham
    Fouda, Samar
    Fouda, Rana
    AlSafadi, Ammar M.
    [J]. BMC NEUROLOGY, 2017, 17
  • [2] Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy
    Adams, David
    Suhr, Ole B.
    Dyck, Peter J.
    Litchy, William J.
    Leahy, Raina G.
    Chen, Jihong
    Gollob, Jared
    Coelho, Teresa
    [J]. BMC NEUROLOGY, 2017, 17
  • [3] 2020 Alzheimer's disease facts and figures
    不详
    [J]. ALZHEIMERS & DEMENTIA, 2020, 16 (03) : 391 - 460
  • [4] Investigation of an amyloid precursor protein protective mutation (A673T) in a North American case-control sample of late-onset Alzheimer's disease
    Bamne, Mikhil N.
    Demirci, F. Yesim
    Berman, Sarah
    Snitz, Beth E.
    Rosenthal, Samantha L.
    Wang, Xingbin
    Lopez, Oscar L.
    Kamboh, M. Ilyas
    [J]. NEUROBIOLOGY OF AGING, 2014, 35 (07) : 1779.e15 - 1779.e16
  • [5] The Genetics of Alzheimer's Disease
    Bertram, Lars
    Tanzi, Rudolph E.
    [J]. MOLECULAR BIOLOGY OF NEURODEGENERATIVE DISEASES, 2012, 107 : 79 - 100
  • [6] T-LYMPHOCYTE-DIRECTED GENE-THERAPY FOR ADA(-) SCID - INITIAL TRIAL RESULTS AFTER 4 YEARS
    BLAESE, RM
    CULVER, KW
    MILLER, AD
    CARTER, CS
    FLEISHER, T
    CLERICI, M
    SHEARER, G
    CHANG, L
    CHIANG, YW
    TOLSTOSHEV, P
    GREENBLATT, JJ
    ROSENBERG, SA
    KLEIN, H
    BERGER, M
    MULLEN, CA
    RAMSEY, WJ
    MUUL, L
    MORGAN, RA
    ANDERSON, WF
    [J]. SCIENCE, 1995, 270 (5235) : 475 - 480
  • [7] Conformational characterization of oligomeric intermediates and aggregates in β-lactoglobulin heat aggregation
    Carrotta, R
    Bauer, R
    Waninge, R
    Rischel, C
    [J]. PROTEIN SCIENCE, 2001, 10 (07) : 1312 - 1318
  • [8] Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance
    Castellano, Joseph M.
    Kim, Jungsu
    Stewart, Floy R.
    Jiang, Hong
    DeMattos, Ronald B.
    Patterson, Bruce W.
    Fagan, Anne M.
    Morris, John C.
    Mawuenyega, Kwasi G.
    Cruchaga, Carlos
    Goate, Alison M.
    Bales, Kelly R.
    Paul, Steven M.
    Bateman, Randall J.
    Holtzman, David M.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (89)
  • [9] Ethics of Human Genome Editing
    Coller, Barry S.
    [J]. ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 : 289 - 305
  • [10] The "rights" of precision drug development for Alzheimer's disease
    Cummings, Jeffrey
    Feldman, Howard H.
    Scheltens, Philip
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2019, 11 (01)